On 30 June 2026, Mike McCormick became the new CEO of Nuwellis, taking over from John Erb.
McCormick enters the CEO role at a time in which the fluid management company is experiencing increasing momentum.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
The Minnesota-based company reported revenues of $2.4m in Q1 2026, indicative of a 26% year-over-year (YoY) uptick.
Upon releasing its Q1 financials, the company highlighted that the results reflected the ongoing adoption of its flagship Aquadex SmartFlow System for removing excess fluid from hospitalised patients experiencing fluid overload (hypervolemia) who have not responded adequately to medical interventions such as diuretics.
As Nuwellis’ new CEO, McCormick intends to increase the market adoption rate of Aquadex and continue the positive momentum the company reported in Q1 2026.
In this episode, Medical Device Network spoke with McCormick to learn more about his plans for driving sustainable value creation for Nuwellis.
Listen to the full episode below:
